StockData
Silo Pharma, Inc. logo

Silo Pharma, Inc. (SILO) stock

SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$1.84−0.07 (-3.66%)

Close on Nov 13, 2026Market cap $2.92MP/E –Yield –

Silo Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

Silo Pharma's gross margin for the twelve months ending Jun 30, 2026 was -14.8%. For fiscal 2025 it was 38.6%, against 91.9% the year before. The highest annual figure on record is 91.9% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202538.6%−53.3
FY2024Dec 31, 202491.9%+0.0
FY2023Dec 31, 202391.9%+0.0
FY2022Dec 31, 202291.9%+422.3
FY2020Dec 31, 2020-330.4%−362.9
FY2019Dec 31, 201932.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-14.8%−106.7
Q4 FY2025Dec 31, 2025-14.8%−106.7
Q3 FY2025Sep 30, 2025-14.8%−106.7
Q2 FY2025Jun 30, 202591.9%+0.0
Q1 FY2025Mar 31, 202591.9%−0.0
Q4 FY2024Dec 31, 202491.9%+0.0
Q3 FY2024Sep 30, 202491.9%+0.0
Q4 FY2023Dec 31, 202391.9%−0.0
Q1 FY2023Jun 30, 202391.9%+67.6
Q4 FY2022Dec 31, 202291.9%+57.0
Q3 FY2022Sep 30, 202291.9%+648.4
Q2 FY2022Jun 30, 202291.9%+172.7
Q2 FY2021Jun 30, 202124.3%−15.5
Q1 FY2021Mar 31, 202134.9%−36.5
Q4 FY2020Dec 31, 2020-556.5%−588.7
Q3 FY2020Sep 30, 2020-80.8%−150.2
Q2 FY2020Jun 30, 202039.8%–
Q1 FY2020Mar 31, 202071.4%–
Q4 FY2019Dec 31, 201932.2%–
Q3 FY2019Sep 30, 201969.4%–

More Silo Pharma figures

See a number that looks wrong?